Orphan & Ultra Orphan Drugs

Summary

Focusing on orphan & ultra orphan drugs, this event will provide a fresh and original perspective on one of the most fascinating fields in market & patient access. Communicating value and cost-effectiveness with payers, regulators and other key stakeholders, in such niche markets, requires innovation & out-of-the box models and strategies.

The event will be unique because unlike other general pricing & reimbursement meetings which are broadly-focused, it will be focused on orphan therapies and will guarantee all participants will access the most relevant case studies & views which directly affects their future business plans and can increase market & patient access.